Highridge Medical key facts
as of Oct 2026- Operator of a medical device manufacturing firm intended to develop and manufacture innovative spinal implant solutions for various surgical approaches.
- Highridge Medical is valued at approximately $375.0M as of Oct 2026 (last reported valuation).
- Notable investors include H.I.G. Capital, Concord Health Partners.
- Status: Privately Held (backing).
Highridge Medical's last reported valuation, Apr 2024. Nothing priced has surfaced since.
- ·Watch Highridge Medical: the Monday email on marks, rounds and moves
Highridge Medical funding rounds
No funding rounds for Highridge Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Highridge Medical
2Highridge Medical valuation
Highridge Medical's last reported valuation was $375 million in Apr 2024. No priced round, secondary trade or fund mark has surfaced since.
Highridge Medical investors
2 investors are on record for Highridge Medical, including H.I.G. Capital and Concord Health Partners. By type, the record holds 1 private equity firm and 1 growth equity firm.
About Highridge Medical
Operator of a medical device manufacturing firm intended to develop and manufacture innovative spinal implant solutions for various surgical approaches. The company's portfolio offers a comprehensive range of spinal implant solutions across different categories, including motion preservation, minimally invasive surgery (MIS), bone healing, and core spine technologies, enabling surgeons to select the most appropriate treatment option for their patients, potentially leading to improved surgical outcomes.
- Sector
- Healthcare
- HQ
- Westminster, CO, United States
- Founded
- 2024
- Employees
- 500
- Website
- highridgemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.